Correction to "Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing"
- PMID: 40583355
- DOI: 10.1002/cpt.3755
Correction to "Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing"
Erratum for
-
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.Clin Pharmacol Ther. 2020 Aug;108(2):253-263. doi: 10.1002/cpt.1856. Epub 2020 May 12. Clin Pharmacol Ther. 2020. PMID: 32285930 Free PMC article.
References
-
- Gautret, P. et al. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. Int. J. Antimicrob. Agents 56, 105949 (2020).
-
- Garcia‐Cremades, M. et al. Optimizing hydroxychloroquine dosing for patients with COVID‐19: an integrative modeling approach for effective drug repurposing. Clin. Pharmacol. Ther. 108(2), 253–263 (2020).
-
- Cavalcanti, A.B. et al. Hydroxychloroquine with or without Azithromycin in mild‐to‐moderate covid‐19. N. Engl. J. Med. 383(21), 2041–2052 (2020).
-
- Farré, N. et al. Prolonged QT Interval in SARS‐CoV‐2 infection: prevalence and prognosis. J. Clin. Med. 9(9), 2712 (2020).
-
- Merino, J.L., Martínez‐Cossiani, M., Iniesta, A., Escobar, C., Rey, J.R. & Castrejón‐Castrejón, S. COVID‐19 and QT interval prolongation: more than just drug toxicity? EP Europace 22(10), 1479 (2020).
Publication types
LinkOut - more resources
Full Text Sources